JP2004520009A5 - - Google Patents

Download PDF

Info

Publication number
JP2004520009A5
JP2004520009A5 JP2002517823A JP2002517823A JP2004520009A5 JP 2004520009 A5 JP2004520009 A5 JP 2004520009A5 JP 2002517823 A JP2002517823 A JP 2002517823A JP 2002517823 A JP2002517823 A JP 2002517823A JP 2004520009 A5 JP2004520009 A5 JP 2004520009A5
Authority
JP
Japan
Prior art keywords
nucleic acid
cell
acid expression
expression construct
construct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002517823A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004520009A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2001/000733 external-priority patent/WO2002012539A2/en
Publication of JP2004520009A publication Critical patent/JP2004520009A/ja
Publication of JP2004520009A5 publication Critical patent/JP2004520009A5/ja
Pending legal-status Critical Current

Links

JP2002517823A 2000-08-08 2001-08-08 核酸構築物、それにより形質転換された血管細胞、血管形成を誘発するためのそれを用いた医薬組成物および方法 Pending JP2004520009A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22372700P 2000-08-08 2000-08-08
PCT/IL2001/000733 WO2002012539A2 (en) 2000-08-08 2001-08-08 Nucleic acid constructs, vascular cells transformed therewith, pharmaceutical compositions and methods utilizing same for inducing angiogenesis

Publications (2)

Publication Number Publication Date
JP2004520009A JP2004520009A (ja) 2004-07-08
JP2004520009A5 true JP2004520009A5 (https=) 2008-09-25

Family

ID=22837748

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002517823A Pending JP2004520009A (ja) 2000-08-08 2001-08-08 核酸構築物、それにより形質転換された血管細胞、血管形成を誘発するためのそれを用いた医薬組成物および方法

Country Status (13)

Country Link
US (1) US7767201B2 (https=)
EP (2) EP1307582B1 (https=)
JP (1) JP2004520009A (https=)
AT (1) ATE397087T1 (https=)
AU (1) AU2001280060A1 (https=)
CA (1) CA2418936A1 (https=)
CZ (1) CZ2003444A3 (https=)
DE (1) DE60134234D1 (https=)
HU (1) HUP0300727A3 (https=)
IL (1) IL154324A0 (https=)
PL (1) PL366000A1 (https=)
WO (1) WO2002012539A2 (https=)
ZA (1) ZA200301386B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7387645B2 (en) * 2003-04-25 2008-06-17 Medtronic Vascular, Inc. Cellular therapy to heal vascular tissue
US20090304650A1 (en) * 2005-05-11 2009-12-10 Scott Edward W Repair of the Bone Marrow Vasculature
EP1948247A4 (en) * 2005-11-15 2010-07-07 Univ Leland Stanford Junior COMPOSITIONS FOR COORDINATED VEGF AND PDGF EXPRESSION AND METHOD OF USE THEREOF
JP5121155B2 (ja) * 2006-03-14 2013-01-16 独立行政法人物質・材料研究機構 形質転換細胞集団の作成方法
US9598673B2 (en) * 2006-05-19 2017-03-21 Creative Medical Health Treatment of disc degenerative disease
US7943590B2 (en) * 2007-03-16 2011-05-17 Multi-Gene Vascular Systems Ltd. Compositions and methods for treating ophthalmic disorders
CN102242148A (zh) * 2010-10-09 2011-11-16 苏州大学 重组载体以及转基因骨髓基质细胞修饰的丝素膜及其应用
US10383916B2 (en) 2012-11-02 2019-08-20 Cornell University Angiogenic conditioning to enhance cardiac cellular reprogramming of fibroblasts of the infarcted myocardium
CN114457003A (zh) * 2020-11-10 2022-05-10 维思尔治疗有限公司 预调节血管细胞用于转导的方法、转导方法和保存转导的细胞的方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4900556A (en) * 1985-04-26 1990-02-13 Massachusetts Institute Of Technology System for delayed and pulsed release of biologically active substances
US6001350A (en) * 1987-12-11 1999-12-14 Somatix Therapy Corp Genetic modification of endothelial cells
US5674722A (en) 1987-12-11 1997-10-07 Somatix Therapy Corporation Genetic modification of endothelial cells
US4950483A (en) * 1988-06-30 1990-08-21 Collagen Corporation Collagen wound healing matrices and process for their production
US5219739A (en) * 1989-07-27 1993-06-15 Scios Nova Inc. DNA sequences encoding bVEGF120 and hVEGF121 and methods for the production of bovine and human vascular endothelial cell growth factors, bVEGF120 and hVEGF121
US5980885A (en) * 1991-07-08 1999-11-09 Neurospheres Holdings Ltd. Growth factor-induced proliferation of neural precursor cells in vivo
DK0642585T3 (da) * 1992-05-18 2006-05-15 Genentech Inc Aktiviering af oligomeriserende receptorer ved anvendelse af fusionerede receptorligander
US5618544A (en) * 1992-08-12 1997-04-08 Bays-Brown Dermatologics, Inc. Method of decreasing cutaneous senescence
DE4228457A1 (de) * 1992-08-27 1994-04-28 Beiersdorf Ag Herstellung von heterodimerem PDGF-AB mit Hilfe eines bicistronischen Vektorsystems in Säugerzellen
US6007987A (en) 1993-08-23 1999-12-28 The Trustees Of Boston University Positional sequencing by hybridization
US5962427A (en) * 1994-02-18 1999-10-05 The Regent Of The University Of Michigan In vivo gene transfer methods for wound healing
US5821919A (en) * 1994-04-29 1998-10-13 Intel Corporation Apparatus for table-driven conversion of pixels from YVU to RGB format
US6090618A (en) * 1996-10-07 2000-07-18 Arch Development Corporation DNA constructs and viral vectors comprising a smooth muscle promoter
US5641750A (en) * 1995-11-29 1997-06-24 Amgen Inc. Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein product
JP2000502682A (ja) * 1995-12-22 2000-03-07 ローカルメッド インコーポレイテッド 血管新生を促進する成長因子の局所的血管内デリバリー
US5785965A (en) * 1996-05-15 1998-07-28 The Board Of Trustees Of The Leland Stanford Junior Univ. VEGF gene transfer into endothelial cells for vascular prosthesis
IL129474A0 (en) * 1996-10-23 2000-02-29 Univ Wake Forest Targeted cytotoxic cells
FI970784A7 (fi) * 1997-02-25 1998-08-26 Nokia Corp Prosessien välinen vuonvalvonta hajautetussa moniprosessoriympäristössä
US6099832A (en) * 1997-05-28 2000-08-08 Genzyme Corporation Transplants for myocardial scars
CA2225185A1 (en) * 1997-08-11 1999-02-11 Peter K. Law Myoblast transfer therapy for relieving pain and for treating behavioral and perceptive abnormalities
CA2266805C (en) * 1998-03-27 2015-04-28 An-Go-Gen Inc. Cell-based gene therapy in the treatment of pulmonary disorders
US6206914B1 (en) * 1998-04-30 2001-03-27 Medtronic, Inc. Implantable system with drug-eluting cells for on-demand local drug delivery
JP4493854B2 (ja) * 1998-12-23 2010-06-30 リジェネロン・ファーマシューティカルズ・インコーポレイテッド リガンドの生物学的活性を増強する方法
EP1016726A1 (en) * 1998-12-30 2000-07-05 Introgene B.V. Gene therapy to promote angiogenesis
US6328762B1 (en) * 1999-04-27 2001-12-11 Sulzer Biologics, Inc. Prosthetic grafts
US6554857B1 (en) * 1999-07-20 2003-04-29 Medtronic, Inc Transmural concentric multilayer ingrowth matrix within well-defined porosity
AU2001291019A1 (en) * 2000-09-15 2002-03-26 Genvec, Inc. Method of modulating neovascularization
US20030027751A1 (en) * 2001-04-10 2003-02-06 Genvec, Inc. VEGF fusion proteins

Similar Documents

Publication Publication Date Title
JP2002513556A5 (https=)
WO2000023471A3 (en) Use of a cytokine-producing lactococcus strain to treat colitis
DE69939327D1 (de) Funktionelle antagonisten von hedgehog-aktivität
WO1999012968A3 (en) Chemokine peptides, variants, derivatives and analogs, their use in methods to inhibit or augment an inflammatory response
AU2001278797A1 (en) Expression vector using for animal cell
WO2002031134A3 (en) Novel serine protease genes related to dppiv
WO2001075087A3 (en) Subtilisin variants
ATE481490T1 (de) Strukturprotein von aav, seine herstellung und verwendung
WO2002002624A3 (en) B7-like molecules and uses thereof
WO2004110472A3 (en) Fusion proteins
AU2790292A (en) Viral recombinant vectors for expression in muscle cells
JP2004520009A5 (https=)
EP1401477A4 (en) Chemokine Beta-1 FUSION PROTEIN
WO1999019359A8 (en) Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle
WO2005003315A3 (en) Compositions and methods for peptide-assisted transfection
WO2003087757A3 (en) Particle-bound human immunodeficiency virus envelope clycoproteins and related compositions and methods
WO2000053776A3 (en) Human kallikrein-like genes
Beutler et al. Retrovirus‐mediated expression of an artificial β‐endorphin precursor in primary fibroblasts
FR2732346B1 (fr) Proteines mutees, codees par un gene env mute de lentivirus, fragments peptidiques inclus dans lesdites proteines, vecteurs d'expression exprimant lesdites proteines mutees et leurs applications
AU7525398A (en) Inhibitors for urokinase receptor
WO2002012468A3 (en) 2,5-dkg permeases
Cochrane et al. Purification of biologically active human immunodeficiency virus rev protein from Escherichia coli
WO2024206274A3 (en) T cell receptors targeting y220c or r175h mutation in p53
DE3682166D1 (de) Herstellung von insektizidprotein von bacillus thuringiensis subsp. aizawai ipl durch die expression von insektizidprotein-gen in wirtszellen.
WO2000006735A8 (en) Interferon alpha hybrids